Tapewire

Nasdaq · USD

PALI

PALISADE BIO, INC.

Export transactions ↓
Tapewire entity
5803
SEC CIK
0001357459
Parsed reports
182

Last 12 months

Inside the activity.

10 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202620
Feb 202602
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202662
Aug 202600
Sep 202600
Oct 202620

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 27, 2021 Filed Apr 29, 2021 21:46 UTC
Dawson Michael JohnChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 2,800 Not disclosed Strike: $26.85 Not disclosed
Disclosure

SEC source: 0001209191-21-029066 · doc4.xml · derivative · entry 5

Dawson Michael John · CIK 0001849790 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,800

Underlying: Common Stock · 2,800 shares

Expires 2030-02-19

F8 · price: Received in the Merger in exchange for a stock option to acquire 103,000 shares of LBS common stock for $0.73 per share.

F1 · derivative.exercise_date: The stock option vested in four equal quarterly installments from the vesting commencement date.

Read SEC document
April 27, 2021 Filed Apr 29, 2021 21:46 UTC
Dawson Michael JohnChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 1,962 Not disclosed Strike: $41.20 Not disclosed
Disclosure

SEC source: 0001209191-21-029066 · doc4.xml · derivative · entry 4

Dawson Michael John · CIK 0001849790 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,962

Underlying: Common Stock · 1,962 shares

Expires 2029-03-22

F7 · price: Received in the Merger in exchange for a stock option to acquire 72,200 shares of LBS common stock for $1.12 per share.

F1 · derivative.exercise_date: The stock option vested in four equal quarterly installments from the vesting commencement date.

Read SEC document
April 27, 2021 Filed Apr 29, 2021 21:46 UTC
Dawson Michael JohnChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 5,084 Not disclosed Strike: $41.20 Not disclosed
Disclosure

SEC source: 0001209191-21-029066 · doc4.xml · derivative · entry 3

Dawson Michael John · CIK 0001849790 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,084

Underlying: Common Stock · 5,084 shares

Expires 2029-03-22

F6 · price: Received in the Merger in exchange for a stock option to acquire 187,000 shares of LBS common stock for $1.12 per share.

F5 · derivative.exercise_date: The stock option vests according to the following schedule: 33% of the shares underlying the option vests on grant date and the remaining 67% vests in eight equal quarterly installments thereafter beginning on March 31, 2019.

Read SEC document
April 27, 2021 Filed Apr 29, 2021 21:46 UTC
Dawson Michael JohnChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 20,391 Not disclosed Strike: $53.33 Not disclosed
Disclosure

SEC source: 0001209191-21-029066 · doc4.xml · derivative · entry 2

Dawson Michael John · CIK 0001849790 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,391

Underlying: Common Stock · 20,391 shares

Expires 2028-07-24

F4 · price: Received in the Merger in exchange for a stock option to acquire 750,000 shares of LBS common stock for $1.45 per share.

F3 · derivative.exercise_date: The stock option vests according to the following schedule: 17% of the shares underlying the option vests on grant date and the remaining 83% vests in 10 quarterly installments thereafter beginning on September 30, 2018.

Read SEC document
April 27, 2021 Filed Apr 29, 2021 21:46 UTC
Dawson Michael JohnChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 5,438 Not disclosed Strike: $27.59 Not disclosed
Disclosure

SEC source: 0001209191-21-029066 · doc4.xml · derivative · entry 1

Dawson Michael John · CIK 0001849790 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,438

Underlying: Common Stock · 5,438 shares

Expires 2027-02-10

F2 · price: Received in exchange for a stock option to acquire 200,000 shares of common stock of Leading BioSciences, Inc. ("LBS") for $0.75 per share, pursuant to the Agreement and Plan of Merger, dated December 16, 2020, among Seneca Biopharma Inc., Townsgate Acquisition Sub 1, Inc. and LBS (the "Merger"). Per the terms of the Merger, each share of LBS's common stock was converted into the right to receive 0.02719 shares of Seneca's common stock. In the Merger, the name of the Issuer was changed from Seneca Biopharma, Inc. to Palisade Bio, Inc.

F1 · derivative.exercise_date: The stock option vested in four equal quarterly installments from the vesting commencement date.

Read SEC document
April 27, 2021 Filed Apr 29, 2021 21:54 UTC
Neal James RDirector
GrantStock Option (Right to Buy) · Derivative 4,406 Not disclosed Strike: $26.85 Not disclosed
Disclosure

SEC source: 0001209191-21-029078 · doc4.xml · derivative · entry 6

Neal James R · CIK 0001600865 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,406

Underlying: Common Stock · 4,406 shares

Expires 2030-07-10

F12 · price: Received in the Merger in exchange for a stock option to acquire 162,069 shares of LBS common stock for $0.73 per share.

F11 · derivative.exercise_date: The stock option vests according to the following schedule: 25% of the shares underlying the option vests on the grant date and the remaining 75% vested in three equal quarterly installments thereafter beginning on September 30, 2020.

Read SEC document
April 27, 2021 Filed Apr 29, 2021 21:54 UTC
Neal James RDirector
GrantStock Option (Right to Buy) · Derivative 1,298 Not disclosed Strike: $41.20 Not disclosed
Disclosure

SEC source: 0001209191-21-029078 · doc4.xml · derivative · entry 5

Neal James R · CIK 0001600865 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,298

Underlying: Common Stock · 1,298 shares

Expires 2029-06-19

F10 · price: Received in the Merger in exchange for a stock option to acquire 47,758 shares of LBS common stock for $1.12 per share.

F9 · derivative.exercise_date: The stock option is fully vested.

Read SEC document
April 27, 2021 Filed Apr 29, 2021 21:54 UTC
Neal James RDirector
GrantStock Option (Right to Buy) · Derivative 5,091 Not disclosed Strike: $41.20 Not disclosed
Disclosure

SEC source: 0001209191-21-029078 · doc4.xml · derivative · entry 4

Neal James R · CIK 0001600865 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,091

Underlying: Common Stock · 5,091 shares

Expires 2029-04-25

F8 · price: Received in the Merger in exchange for a stock option to acquire 187,250 shares of LBS common stock for $1.12 per share.

F7 · derivative.exercise_date: The stock option vested according to the following schedule: 25% of the shares underlying the option vested on the grant date and the remaining 75% vested in three equal quarterly installments thereafter beginning on June 30, 2019.

Read SEC document
April 27, 2021 Filed Apr 29, 2021 21:54 UTC
Neal James RDirector
GrantStock Option (Right to Buy) · Derivative 1,359 Not disclosed Strike: $53.33 Not disclosed
Disclosure

SEC source: 0001209191-21-029078 · doc4.xml · derivative · entry 3

Neal James R · CIK 0001600865 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,359

Underlying: Common Stock · 1,359 shares

Expires 2028-07-24

F6 · price: Received in the Merger in exchange for a stock option to acquire 50,000 shares of LBS common stock for $1.45 per share.

F5 · derivative.exercise_date: The stock option vested according to the following schedule: 50% of the shares underlying the option vested on the grant date and the remaining 50% vested in two equal quarterly installments thereafter beginning on September 30, 2018.

Read SEC document
April 27, 2021 Filed Apr 29, 2021 21:54 UTC
Neal James RDirector
GrantStock Option (Right to Buy) · Derivative 3,398 Not disclosed Strike: $53.33 Not disclosed
Disclosure

SEC source: 0001209191-21-029078 · doc4.xml · derivative · entry 2

Neal James R · CIK 0001600865 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,398

Underlying: Common Stock · 3,398 shares

Expires 2028-04-05

F4 · price: Received in the Merger in exchange for a stock option to acquire 125,000 shares of LBS common stock for $1.45 per share.

F3 · derivative.exercise_date: The stock option vested according to the following schedule: 25% of the shares underlying the option vested on the grant date and the remaining 75% vested in three equal quarterly installments thereafter beginning on June 30, 2018.

Read SEC document
April 27, 2021 Filed Apr 29, 2021 21:54 UTC
Neal James RDirector
GrantStock Option (Right to Buy) · Derivative 849 Not disclosed Strike: $27.59 Not disclosed
Disclosure

SEC source: 0001209191-21-029078 · doc4.xml · derivative · entry 1

Neal James R · CIK 0001600865 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 849

Underlying: Common Stock · 849 shares

Expires 2027-11-10

F2 · price: Received in exchange for a stock option to acquire 31,250 shares of common stock of Leading BioSciences, Inc. ("LBS") for $0.75 per share, pursuant to the Agreement and Plan of Merger, dated December 16, 2020, among Seneca Biopharma Inc., Townsgate Acquisition Sub 1, Inc. and LBS (the "Merger"). Per the terms of the Merger, each share of LBS's common stock was converted into the right to receive 0.02719 shares of Seneca's common stock. In the Merger, the name of the Issuer was changed from Seneca Biopharma, Inc. to Palisade Bio, Inc.

F1 · derivative.exercise_date: The stock option vested in four equal quarterly installments from the vesting commencement date.

Read SEC document
April 01, 2021 Filed Apr 26, 2021 23:55 UTC GrantRestricted Stock Units · Derivative 6,000 $0.00 $0.00
Disclosure

SEC source: 0001171843-21-002778 · ownership.xml · derivative · entry 1

Mazzo David J · CIK 0001334549 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common Stock · 6,000 shares

Expires not disclosed

F1 · security: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22.

F2 · security: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F1 · shares: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22.

F2 · shares: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F1 · derivative.exercise_date: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22.

F1 · derivative.expiration_date: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22.

Read SEC document
April 01, 2021 Filed Apr 26, 2021 23:53 UTC GrantRestricted Stock Units · Derivative 6,000 $0.00 $0.00
Disclosure

SEC source: 0001171843-21-002777 · ownership.xml · derivative · entry 1

GRAY MARY ANN · CIK 0001261974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common Stock · 6,000 shares

Expires not disclosed

F1 · security: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22.

F2 · security: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F1 · shares: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22.

F2 · shares: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F1 · derivative.exercise_date: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22.

F1 · derivative.expiration_date: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22.

Read SEC document
April 01, 2021 Filed Apr 26, 2021 23:52 UTC GrantRestricted Stock Units · Derivative 6,000 $0.00 $0.00
Disclosure

SEC source: 0001171843-21-002776 · ownership.xml · derivative · entry 1

Csimma Cristina · CIK 0001501623 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common Stock · 6,000 shares

Expires not disclosed

F1 · security: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22.

F2 · security: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F1 · shares: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22.

F2 · shares: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F1 · derivative.exercise_date: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22.

F1 · derivative.expiration_date: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22.

Read SEC document
April 01, 2021 Filed Apr 26, 2021 23:51 UTC
Wei BinxianDirector
GrantRestricted Stock Units · Derivative 6,000 $0.00 $0.00
Disclosure

SEC source: 0001171843-21-002775 · ownership.xml · derivative · entry 1

Wei Binxian · CIK 0001773586 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common Stock · 6,000 shares

Expires not disclosed

F1 · security: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22.

F2 · security: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F1 · shares: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22.

F2 · shares: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F1 · derivative.exercise_date: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22.

F1 · derivative.expiration_date: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2021 and ending March 31, 2022. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/21, 9/30/21, 12/31/21, and 3/31/22.

Read SEC document
April 03, 2020 Filed Apr 7, 2020 21:32 UTC GrantRestricted Stock Units · Derivative 6,000 $0.00 $0.00
Disclosure

SEC source: 0001171843-20-002464 · ownership.xml · derivative · entry 1

Csimma Cristina · CIK 0001501623 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common Stock · 6,000 shares

Expires not disclosed

F1 · security: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21.

F2 · security: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F1 · shares: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21.

F2 · shares: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F1 · derivative.exercise_date: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21.

F3 · derivative.expiration_date: N/A

Read SEC document
April 03, 2020 Filed Apr 7, 2020 21:49 UTC
Wei BinxianDirector
GrantRestricted Stock Units · Derivative 6,000 $0.00 $0.00
Disclosure

SEC source: 0001171843-20-002465 · ownership.xml · derivative · entry 1

Wei Binxian · CIK 0001773586 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common Stock · 6,000 shares

Expires not disclosed

F1 · security: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21.

F2 · security: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F1 · shares: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21.

F2 · shares: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F1 · derivative.exercise_date: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21.

F3 · derivative.expiration_date: N/A

Read SEC document
April 03, 2020 Filed Apr 7, 2020 21:31 UTC GrantRestricted Stock Units · Derivative 6,000 $0.00 $0.00
Disclosure

SEC source: 0001171843-20-002463 · ownership.xml · derivative · entry 1

GRAY MARY ANN · CIK 0001261974 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common Stock · 6,000 shares

Expires not disclosed

F1 · security: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21.

F2 · security: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F1 · shares: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21.

F2 · shares: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F1 · derivative.exercise_date: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21.

F3 · derivative.expiration_date: N/A

Read SEC document
April 03, 2020 Filed Apr 7, 2020 21:29 UTC GrantRestricted Stock Units · Derivative 6,000 $0.00 $0.00
Disclosure

SEC source: 0001171843-20-002462 · ownership.xml · derivative · entry 1

Mazzo David J · CIK 0001334549 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common Stock · 6,000 shares

Expires not disclosed

F1 · security: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21.

F2 · security: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F1 · shares: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21.

F2 · shares: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F1 · derivative.exercise_date: Represents partial compensation for services as a director of the Issuer for the board year commencing on April 1, 2020 and ending March 31, 2021. Provided the Reporting Person is a service provider to the Issuer at the time of vesting, the RSU's will vest in equal quarterly amounts on 6/30/20, 9/30/20, 12/31/20, and 3/31/21.

F3 · derivative.expiration_date: N/A

Read SEC document
July 01, 2019 Filed Jul 3, 2019 21:36 UTC GrantCommon Stock 166,667 $0.00 $0.00
Disclosure

SEC source: 0001171843-19-004419 · ownership.xml · nonDerivative · entry 1

SMITH SANDFORD D · CIK 0001243004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 219,916

F1 · security: The shares represented are restricted stock grants pursuant to 50% of compensatory Annual Grant for director services equal to $50,0000. The shares vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/2020.

Read SEC document
July 01, 2019 Filed Jul 3, 2019 21:35 UTC GrantCommon Stock Purchase Option · Derivative 187,510 $0.00 Strike: $0.30 $0.00
Disclosure

SEC source: 0001171843-19-004417 · ownership.xml · derivative · entry 1

OGILVIE SCOTT VARDE · CIK 0001379413 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 187,510

Underlying: Common Stock · 187,510 shares

Expires 2029-07-01

F1 · security: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20.

F1 · derivative.exercise_date: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20.

Read SEC document
July 01, 2019 Filed Jul 3, 2019 21:35 UTC GrantCommon Stock Purchase Option · Derivative 187,510 $0.00 Strike: $0.30 $0.00
Disclosure

SEC source: 0001171843-19-004418 · ownership.xml · derivative · entry 1

OLDAKER WILLIAM CLYDE · CIK 0001397571 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 187,510

Underlying: Common Stock · 187,510 shares

Expires 2029-07-01

F1 · security: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20.

F1 · derivative.exercise_date: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20.

Read SEC document
July 01, 2019 Filed Jul 3, 2019 21:34 UTC GrantCommon Stock Purchase Option · Derivative 187,510 $0.00 Strike: $0.30 $0.00
Disclosure

SEC source: 0001171843-19-004416 · ownership.xml · derivative · entry 1

Mazzo David J · CIK 0001334549 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 187,510

Underlying: Common Stock · 187,510 shares

Expires 2029-07-01

F1 · security: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20.

F1 · derivative.exercise_date: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20.

Read SEC document
July 01, 2019 Filed Jul 3, 2019 21:33 UTC GrantCommon Stock Purchase Option · Derivative 187,510 $0.00 Strike: $0.30 $0.00
Disclosure

SEC source: 0001171843-19-004415 · ownership.xml · derivative · entry 1

Csimma Cristina · CIK 0001501623 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 187,510

Underlying: Common Stock · 187,510 shares

Expires 2029-07-01

F1 · security: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20.

F1 · derivative.exercise_date: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20.

Read SEC document
July 01, 2019 Filed Oct 11, 2019 23:23 UTC Amendment GrantCommon Stock Purchase Option · Derivative 10,106 $0.00 Strike: $6.00 $0.00
Disclosure

SEC source: 0001171843-19-006480 · ownership.xml · derivative · entry 1

OGILVIE SCOTT VARDE · CIK 0001379413 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,106

Underlying: Common Stock · 10,106 shares

Expires 2029-07-01

F1 · security: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20.

F3 · security: This amendment is being filed to correct a scrivener's error with regard to the option amount previously reported.

F2 · derivative.exercise_price: All exercise prices and share amounts reported in this Form 4/A reflect a 1-for-20 reverse split that occurred on July 17, 2019.

F2 · shares: All exercise prices and share amounts reported in this Form 4/A reflect a 1-for-20 reverse split that occurred on July 17, 2019.

F3 · shares: This amendment is being filed to correct a scrivener's error with regard to the option amount previously reported.

F1 · derivative.exercise_date: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20.

Read SEC document
July 01, 2019 Filed Oct 11, 2019 23:25 UTC Amendment GrantCommon Stock Purchase Option · Derivative 10,106 $0.00 Strike: $6.00 $0.00
Disclosure

SEC source: 0001171843-19-006481 · ownership.xml · derivative · entry 1

Csimma Cristina · CIK 0001501623 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,106

Underlying: Common Stock · 10,106 shares

Expires 2029-07-01

F1 · security: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20.

F3 · security: This amendment is being filed to correct a scrivener's error with regard to the option amount previously reported.

F2 · derivative.exercise_price: All exercise prices and share amounts reported in this Form 4/A reflect a 1-for-20 reverse split that occurred on July 17, 2019.

F2 · shares: All exercise prices and share amounts reported in this Form 4/A reflect a 1-for-20 reverse split that occurred on July 17, 2019.

F3 · shares: This amendment is being filed to correct a scrivener's error with regard to the option amount previously reported.

F1 · derivative.exercise_date: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20.

Read SEC document
July 01, 2019 Filed Oct 11, 2019 23:27 UTC Amendment GrantCommon Stock Purchase Option · Derivative 10,106 $0.00 Strike: $6.00 $0.00
Disclosure

SEC source: 0001171843-19-006482 · ownership.xml · derivative · entry 1

Mazzo David J · CIK 0001334549 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,106

Underlying: Common Stock · 10,106 shares

Expires 2029-07-01

F1 · security: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20.

F3 · security: This amendment is being filed to correct a scrivener's error with regard to the option amount previously reported.

F2 · derivative.exercise_price: All exercise prices and share amounts reported in this Form 4/A reflect a 1-for-20 reverse split that occurred on July 17, 2019.

F2 · shares: All exercise prices and share amounts reported in this Form 4/A reflect a 1-for-20 reverse split that occurred on July 17, 2019.

F3 · shares: This amendment is being filed to correct a scrivener's error with regard to the option amount previously reported.

F1 · derivative.exercise_date: Represents 50% of compensatory Annual Grant for director services equal to $50,000. The options vest quarterly on 9/30/19, 12/31/19, 3/31/20, and 6/30/20.

Read SEC document
July 02, 2018 Filed Jul 5, 2018 20:51 UTC GrantCommon Stock Purchase Option · Derivative 59,660 $0.00 Strike: $1.11 $0.00
Disclosure

SEC source: 0001171843-18-005068 · formfour.xml · derivative · entry 1

WESTREICH STANLEY · CIK 0001238046 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,660

Underlying: Common Stock · 59,660 shares

Expires 2028-07-02

F1 · security: Represents 50% of compensatory Annual Grant for director services of $100,000. The options vest quarterly on 9/30/18, 12/31/18, 3/31/19, and 6/30/19.

F1 · derivative.exercise_date: Represents 50% of compensatory Annual Grant for director services of $100,000. The options vest quarterly on 9/30/18, 12/31/18, 3/31/19, and 6/30/19.

Read SEC document
July 02, 2018 Filed Jul 5, 2018 20:50 UTC GrantCommon Stock Purchase Option · Derivative 59,660 $0.00 Strike: $1.11 $0.00
Disclosure

SEC source: 0001171843-18-005067 · formfour.xml · derivative · entry 1

Csimma Cristina · CIK 0001501623 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,660

Underlying: Common Stock · 59,660 shares

Expires 2028-07-02

F1 · security: Represents 50% of compensatory Annual Grant for director services of $100,000. The options vest quarterly on 9/30/18, 12/31/18, 3/31/19, and 6/30/19.

F1 · derivative.exercise_date: Represents 50% of compensatory Annual Grant for director services of $100,000. The options vest quarterly on 9/30/18, 12/31/18, 3/31/19, and 6/30/19.

Read SEC document
July 02, 2018 Filed Jul 5, 2018 20:32 UTC GrantCommon Stock Purchase Option · Derivative 59,660 $0.00 Strike: $1.11 $0.00
Disclosure

SEC source: 0001171843-18-005065 · formfour.xml · derivative · entry 1

OGILVIE SCOTT VARDE · CIK 0001379413 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,660

Underlying: Common Stock · 59,660 shares

Expires 2028-07-02

F1 · security: Represents 50% of compensatory Annual Grant for director services of $100,000. The options vest quarterly on 9/30/18, 12/31/18, 3/31/19, and 6/30/19.

F1 · derivative.exercise_date: Represents 50% of compensatory Annual Grant for director services of $100,000. The options vest quarterly on 9/30/18, 12/31/18, 3/31/19, and 6/30/19.

Read SEC document
July 02, 2018 Filed Jul 5, 2018 20:31 UTC GrantCommon Stock Purchase Option · Derivative 59,660 $0.00 Strike: $1.11 $0.00
Disclosure

SEC source: 0001171843-18-005064 · formfour.xml · derivative · entry 1

OLDAKER WILLIAM CLYDE · CIK 0001397571 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,660

Underlying: Common Stock · 59,660 shares

Expires 2028-07-02

F1 · security: Represents 50% of compensatory Annual Grant for director services of $100,000. The options vest quarterly on 9/30/18, 12/31/18, 3/31/19, and 6/30/19.

F1 · derivative.exercise_date: Represents 50% of compensatory Annual Grant for director services of $100,000. The options vest quarterly on 9/30/18, 12/31/18, 3/31/19, and 6/30/19.

Read SEC document
July 02, 2018 Filed Jul 5, 2018 20:30 UTC GrantCommon Stock 45,046 $0.00 $0.00
Disclosure

SEC source: 0001171843-18-005063 · formfour.xml · nonDerivative · entry 1

SMITH SANDFORD D · CIK 0001243004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,899

F1 · security: The shares represented are restricted stock grants pursuant to 50% of compensatory Annual Grant for director services of $100,000. The shares vest quarterly on 9/30/18, 12/31/18, 3/31/19, and 6/30/2019.

Read SEC document
November 07, 2017 Filed Nov 9, 2017 21:00 UTC
Daly Richard JDirector · Chief Executive Officer
GrantCommon Stock Purchase Option · Derivative 100,000 $0.00 Strike: $1.12 $0.00
Disclosure

SEC source: 0001171843-17-006832 · formfour.xml · derivative · entry 1

Daly Richard J · CIK 0001635393 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2027-11-07

F1 · security: Represents a discretionary grant to Employee. The options vest quarterly on 2/718, 5/7/18, 8/7/18, and 11/7/18.

Read SEC document
July 14, 2017 Filed Jul 18, 2017 20:32 UTC GrantCommon Stock 18,622 $0.00 $0.00
Disclosure

SEC source: 0001171843-17-004171 · formfour.xml · nonDerivative · entry 1

WESTREICH STANLEY · CIK 0001238046 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,281

F1 · security: The shares represented are restricted stock grants pursuant to compensatory Annual Grant for director services of $100,000. The shares vest quarterly on 9/30/17, 12/31/17, 3/31/18, and 6/30/2018.

Read SEC document
July 14, 2017 Filed Jul 18, 2017 20:32 UTC GrantRestricted Stock Units · Derivative 9,311 $0.00 $0.00
Disclosure

SEC source: 0001171843-17-004170 · formfour.xml · derivative · entry 1

SMITH SANDFORD D · CIK 0001243004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,311

Underlying: Common Stock · 9,311 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.

F2 · shares: Represents 50% of compensatory Annual Grant for director services of $100,000. The RSU's vest quarterly on 9/30/17, 12/31/17, 3/31/18, and 6/30/18.

F2 · derivative.exercise_date: Represents 50% of compensatory Annual Grant for director services of $100,000. The RSU's vest quarterly on 9/30/17, 12/31/17, 3/31/18, and 6/30/18.

F2 · derivative.expiration_date: Represents 50% of compensatory Annual Grant for director services of $100,000. The RSU's vest quarterly on 9/30/17, 12/31/17, 3/31/18, and 6/30/18.

Read SEC document
July 14, 2017 Filed Jul 18, 2017 20:31 UTC GrantCommon Stock 18,622 $0.00 $0.00
Disclosure

SEC source: 0001171843-17-004169 · formfour.xml · nonDerivative · entry 1

OLDAKER WILLIAM CLYDE · CIK 0001397571 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,763

F1 · security: The shares represented are restricted stock grants pursuant to compensatory Annual Grant for director services of $100,000. The shares vest quarterly on 9/30/17, 12/31/17, 3/31/18, and 6/30/2018.

Read SEC document
July 14, 2017 Filed Jul 18, 2017 20:30 UTC GrantCommon Stock Purchase Option · Derivative 13,574 $0.00 Strike: $5.37 $0.00
Disclosure

SEC source: 0001171843-17-004168 · formfour.xml · derivative · entry 1

OGILVIE SCOTT VARDE · CIK 0001379413 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,574

Underlying: Common Stock · 13,574 shares

Expires 2027-07-14

F1 · security: Represents 50% of compensatory Annual Grant for director services of $100,000. The options vest quarterly on 9/30/17, 12/31/17, 3/31/18, and 6/30/18.

F1 · derivative.exercise_date: Represents 50% of compensatory Annual Grant for director services of $100,000. The options vest quarterly on 9/30/17, 12/31/17, 3/31/18, and 6/30/18.

Read SEC document
May 17, 2017 Filed May 18, 2017 17:02 UTC
Daly Richard JDirector · Chief Executive Officer
PurchaseCommon Stock 7,500 $4.00 $30,000.00
Disclosure

SEC source: 0001171843-17-003169 · formfour.xml · nonDerivative · entry 1

Daly Richard J · CIK 0001635393 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,312

F1 · security: Reporting person, Richard Daly, purchased 7,500 shares of common stock in a private transaction directly from the issuer on May 17, 2017.

Read SEC document
April 11, 2017 Filed Apr 13, 2017 20:20 UTC GrantCommon Stock Purchase Option · Derivative 33,408 $0.00 Strike: $4.96 $0.00
Disclosure

SEC source: 0001171843-17-002114 · f4_westreich041317.xml · derivative · entry 1

WESTREICH STANLEY · CIK 0001238046 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,408

Underlying: Common Stock · 33,408 shares

Expires 2024-04-11

F1 · security: On April 11, 2017, Neuralstem issued a conditional grant to reporting person for services rendered as a director for the 2016 fiscal board year. The grant is 100% vested on the grant date and is being made on a conditional basis pursuant to NASDAQ market rules and will not be exercisable and will be subject to forfeiture if applicable shareholder approval is not received.

F1 · derivative.exercise_date: On April 11, 2017, Neuralstem issued a conditional grant to reporting person for services rendered as a director for the 2016 fiscal board year. The grant is 100% vested on the grant date and is being made on a conditional basis pursuant to NASDAQ market rules and will not be exercisable and will be subject to forfeiture if applicable shareholder approval is not received.

Read SEC document
March 24, 2017 Filed Mar 27, 2017 20:06 UTC
LLOYD JONES JONATHAN BRIANChief Financial Officer
PurchaseCommon Stock 5,455 $5.50 $30,002.50
Disclosure

SEC source: 0001171843-17-001771 · formfour.xml · nonDerivative · entry 1

LLOYD JONES JONATHAN BRIAN · CIK 0001567657 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,859

F1 · security: Reporting person, Jonathan Lloyd Jones, purchased 5,455 shares of common stock in a private transaction directly from the issuer.

Read SEC document
February 24, 2017 Filed Feb 27, 2017 21:30 UTC
Daly Richard JDirector · Chief Executive Officer
PurchaseCommon Stock 2,591 $3.86 $10,001.26
Disclosure

SEC source: 0001171843-17-001161 · form4.xml · nonDerivative · entry 1

Daly Richard J · CIK 0001635393 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,812

F1 · security: Reporting person, Richard Daly, purchased 2,591 shares of common stock in a private transaction directly from the issuer.

Read SEC document
January 25, 2017 Filed Jan 27, 2017 21:18 UTC
Daly Richard JDirector · Chief Executive Officer
PurchaseCommon Stock 2,841 $3.52 $10,000.32
Disclosure

SEC source: 0001171843-17-000498 · form4daly.xml · nonDerivative · entry 1

Daly Richard J · CIK 0001635393 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,221

F1 · security: Reporting person, Richard Daly, purchased 2,841 shares of common stock in a private transaction directly from the issuer.

Read SEC document
December 23, 2016 Filed Dec 30, 2016 21:05 UTC
Daly Richard JDirector · Chief Executive Officer
PurchaseCommon Stock 32,259 $0.31 $10,000.29
Disclosure

SEC source: 0001171843-16-013813 · formfour.xml · nonDerivative · entry 1

Daly Richard J · CIK 0001635393 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,939

F1 · security: Reporting person, Richard Daly, purchased 32,259 shares of common stock in a private transaction directly from the issuer.

Read SEC document
November 25, 2016 Filed Nov 28, 2016 22:36 UTC
Daly Richard JDirector · Chief Executive Officer
PurchaseCommon Stock 35,715 $0.28 $10,000.20
Disclosure

SEC source: 0001171843-16-013393 · formfour.xml · nonDerivative · entry 1

Daly Richard J · CIK 0001635393 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,680

F1 · security: Reporting person, Richard Daly, purchased 35,715 shares of common stock in a private transaction directly from the issuer.

Read SEC document
October 25, 2016 Filed Oct 27, 2016 20:05 UTC
Daly Richard JDirector · Chief Executive Officer
PurchaseCommon Stock 35,715 $0.28 $10,000.20
Disclosure

SEC source: 0001171843-16-012678 · formfour.xml · nonDerivative · entry 1

Daly Richard J · CIK 0001635393 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,965

F1 · security: Reporting person, Richard Daly, purchased 35,715 shares of common stock in a private transaction directly from the issuer.

Read SEC document
September 23, 2016 Filed Sep 26, 2016 20:51 UTC
LLOYD JONES JONATHAN BRIANChief Financial Officer
PurchaseCommon Stock 31,250 $0.32 $10,000.00
Disclosure

SEC source: 0001171843-16-012275 · formfour.xml · nonDerivative · entry 1

LLOYD JONES JONATHAN BRIAN · CIK 0001567657 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,250

F1 · security: Reporting person, Jonathan Lloyd Jones, purchased 31,250 shares of common stock in a private transaction directly from the issuer.

Read SEC document
September 23, 2016 Filed Sep 26, 2016 20:50 UTC
Daly Richard JDirector · Chief Executive Officer
PurchaseCommon Stock 31,250 $0.32 $10,000.00
Disclosure

SEC source: 0001171843-16-012274 · f4_092616daly.xml · nonDerivative · entry 1

Daly Richard J · CIK 0001635393 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,250

F1 · security: Reporting person, Richard Daly, purchased 31,250 shares of common stock in a private transaction directly from the issuer.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.